APELLIS PHARMACEUTICALS INC (APLS) 66.18 +1.2 (+1.85%)
66.18 +1.2 (+1.85%)
US03753U1060 - Common Stock - After market: 66.18 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 87.38. This target is 32.03% above the current price.
APLS was analyzed by 23 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about APLS.
In the previous month the buy percentage consensus was at a similar level.
APLS was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-23 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-22 | Needham | Maintains | Buy |
| 2023-02-22 | Raymond James | Maintains | Strong Buy |
| 2023-02-21 | Needham | Reiterate | Buy |
| 2023-02-21 | Stifel | Maintains | Buy |
| 2023-02-21 | Baird | Maintains | Outperform |
| 2023-02-21 | Citigroup | Maintains | Buy |
| 2023-02-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2022-11-15 | JP Morgan | Maintains | Overweight |
| 2022-11-10 | Jefferies | Downgrade | Buy -> Hold |
| 2022-11-08 | Credit Suisse | Maintains | Neutral |
| 2022-10-18 | Raymond James | Maintains | Strong Buy |
| 2022-09-12 | Wedbush | Maintains | Neutral |
| 2022-09-08 | Stifel | Maintains | Buy |
| 2022-08-18 | Oppenheimer | Maintains | Outperform |
| 2022-08-09 | Raymond James | Maintains | Strong Buy |
| 2022-08-09 | Goldman Sachs | Maintains | Buy |
| 2022-08-09 | Credit Suisse | Maintains | Neutral |
| 2022-07-20 | Citigroup | Maintains | Buy |
| 2022-07-19 | HC Wainwright & Co. | Initiate | Buy |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-05-05 | Raymond James | Maintains | Strong Buy |
| 2022-05-05 | Credit Suisse | Maintains | Neutral |
| 2022-04-14 | Roth Capital | Downgrade | Neutral -> Sell |
| 2022-03-07 | Goldman Sachs | Maintains | Buy |
| 2022-03-01 | Raymond James | Maintains | Strong Buy |
| 2022-01-11 | Raymond James | Maintains | Strong Buy |
| 2021-12-08 | Wells Fargo | Initiate | Overweight |
| 2021-11-29 | Roth Capital | Downgrade | Buy -> Neutral |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA